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Summary: 
The clustered regularly interspaced palindromic repeat (CRISPR) and CRISPR-associated 
(Cas) genes are widely spread in bacteria and archaea, representing an intracellular defence 
system against invading viruses and plasmids. In the system, fragments from foreign DNA are 
captured and integrated into the host genome at the CRISPR locus. The locus is transcribed 
and the resulting RNAs are processed by Cas6 into small CRISPR RNA (crRNA) that guides a 
variety of effector complexes to degrade the invading genetic elements. Many bacteria and 
archaea have one major type of effector complex. However, Sulfolobus solfataricus strain P2 
has six CRISPR loci with two families of repeat, four cas6 genes, and three different types of 
effector complex. These features make S. solfataricus an important model for studying 
CRISPR-Cas systems. Here, we review our current understanding of crRNA biogenesis and 
its effector complexes, Type IA and Type IIIB, in S. solfataricus. We also discuss the 
differences in terms of mechanisms between the Type IIIB systems in S. solfataricus and 
Pyrococcus furiosus.  
 
 
Introduction 
The cluster of regularly interspersed palindromic repeats (CRISPR) and CRISPR-associated 
(Cas) genes are found in 48% of bacteria and 84% of archaea  
[1]. The complete sequence of the Sulfolobus solfataricus P2 genome revealed 6 loci of clustered 
tandem repeats (then known as “long cluster of tandem repeats” (LCTR’s)). These had 
previously been observed in the Sulfolobus conjugative plasmid pNOB8, and their function was 
originally thought to be related to chromosome partitioning [2].  Subsequently these repeat 
families, renamed as Short Regularly Spaced Repeats (SRSR’s), were identified in other 
crenarchaeal genomes [3]. Transcription of Sulfolobus SRSR loci to generate small RNA’s was 
first reported in 2005 [4]. Genome analysis revealed the presence of gene families often found 
adjacent to the repeats, now known as CRISPR’s [5]. These CRISPR-associated (Cas) proteins 
were originally thought to constitute a DNA repair system [6] and a subset of these were given 
the collective name “Repair Associated Mysterious Proteins” or RAMPs. Subsequently, it was 
observed that the spacers found between repeats in several organisms including S. solfataricus 
were derived from viral genomes [7-9], leading to the proposal that they constituted an antiviral 
defence system [10,11]. The RAMP acronym was revised to stand for “Repeat Associated 
Mysterious Protein” [10].  
Fast-forward seven years and the progress made in understanding the mechanisms underlying 
the CRISPR-Cas system has been astounding. We now understand that CRISPR loci are 
transcribed to generate a long pre-CRISPR RNA (pre-crRNA) that is processed by a 
ribonuclease to generate unit length crRNAs that are loaded into different types of Cas-protein 
complexes. These complexes provide immunity against invading genetic elements through 
homology-directed 
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detection and degradation of foreign nucleic acids in a process known as “Interference” 
(reviewed in [12-15]). Interference complexes have been classified into three major types (I, II 
and III), with each major type characterised by a unique signature gene [16]. The signature 
genes for the three types are cas3, cas9 and cas10, respectively. Within these three types, 
CRISPR-Cas systems have been further divided into 10 subtypes (I-A to I-F, II-A, II-B, III-A and 
III-B) [16].  Meanwhile, the acquisition process for new spacers is still not well understood, 
although the conserved Cas1 and Cas2 proteins play an important role [17,18]. 
 
Many bacteria and archaea examined so far have one type of interference complex. Most 
Sulfolobus species, however, harbour complex and diverse CRISPR-Cas systems [11]. In 
particular, Sulfolobus solfataricus strain P2 has six CRISPR loci (A-F) with repeats belonging to 
two different families [11], four cas6 genes and up to seven different interference complexes (2 of 
Type I-A, 3 of Type III-B and one of Type III-A) (Figure 1). These features make S. solfataricus 
an important model system for the study of CRISPR-Cas immune systems. Hereafter we review 
the current state of our understanding of Sulfolobus crRNA biogenesis and interference. 
 
 
Figure 1. Organisation of the genomic CRISPR-Cas locus of S. solfataricus strain P2. CRISPR 
loci are indicated as bold letters (A-F) with the number of spacers indicated. Cas protein effector 
complexes are boxed and labelled with roman numerals; cas genes are colour coded according 
to the key. Four cas6 ribonuclease genes are shown in red and putative transcriptional control 
proteins of the Csx1 / Csm1 / Cas3 families are indicated in light green. Selected sso gene 
numbers are indicated below the genes. 
 
crRNA biogenesis 
crRNA biogenesis and loading into effector complexes is potentially very complex in S. 
solfataricus. There are four clear Cas6 paralogues that cluster in two distinct families. These may 
be expressed at different levels and have differing specificities for the two different families of 
CRISPR repeat that exist in the organism, providing an initial layer of complexity. Furthermore, 
Cas6 enzymes do not associate stably with the Type I-A or Type III effector complexes ([19,20] 
and unpublished observations). Therefore, the determination of factors affecting crRNA cleavage 
by Cas6 or loading into the effector complexes will be important to understand the molecular 
mechanism and coordination between Cas6 and the complexes. 
 
Cas6 ribonuclease 
The S. solfataricus P2 genome encodes four clear Cas6 proteins. Two of them (Sso1437 and 
Sso2004) have been shown to cleave CRISPR repeat RNA at 8 nt from the 3’ end [19,21,22]. 
Analysis of crystal structure of crRNA-bound Sso2004 revealed that the protein adopts a dimeric 
arrangement and the RNA a hairpin structure. In contrast, PfuCas6 contains two tandem RAMP 
domains that form a groove, in which the repeat RNA wraps around the protein without forming a 
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hairpin structure, analogous to the string around a yoyo [23]. Although RNA conformation is 
dramatically different between the two archaeal crRNA-bound Cas6 proteins, crRNA adopts a 
similar secondary structure when binding to SsoCas6 and bacterial Cas6 proteins such as 
TtCas6e and PaCas6f (reviewed in[24]). These data indicate that SsoCas6 might utilise a crRNA 
recognition mechanism similar to that in bacteria but different from that of PfuCas6.  
 
Cas6 is a metal-independent ribonuclease that generates products with 5’-hydroxyl and 2’, 3’-
cyclic phosphate ends, indicating a general acid/base cleaving mechanism. The catalytic activity 
requires an essential histidine residue in the active site in almost all Cas6 proteins [25,26]. But 
the SsoCas6 and other crenarchaeal Cas6 proteins lack such a histidine around the presumed 
active site, suggesting these crenarchaeal enzymes might utilise a different mechanism for 
cleavage. Identification of four conserved basic residues (K25, K28, K51 and R231) important but 
not essential for catalytic activity began to shed light on this catalytic mechanism [21]. 
Interestingly, none of these individual residues is absolutely essential for catalysis.  
 
crRNAs produced by Cas6 programme three types of effector complex in S. solfataricus (Figure 
2). But pull-down assays with either Cascade subunits or CMR subunits did not lead to co-
precipitation of Cas6 proteins [19,20]. The failure suggests that interaction between Cas6 and the 
CRISPR-Cas complexes, if it exists, is weak and transient. Therefore, it is more likely that crRNA 
needs to be released from its processing enzyme and then loaded into its effector complexes 
after diffusion. This speculation is compatible with a potential for Cas6 to perform multiple rounds 
of crRNA binding, cleavage and release, unlike the bacterial Cas6 enzymes. 
 
Type IA – Cascade complex 
Three operons encoding type I-A effector complexes are present in the S. solfataricus genome 
(Figure 1). The gene order is conserved, with each beginning with the csa5 gene coding for the 
so-called “small” subunit, followed by the cas7 and cas5 genes and then the cas3’ and cas3’’ 
genes that encode the helicase and nuclease subunits of Cas3. In one gene cluster there is an 
extra gene that appears to encode a highly divergent member of the Cas8a2 family (Figure 1). 
The Sulfolobus type I-A complex has not been purified from the organism as a defined complex 
as has been achieved in other systems. The Cas7 and Cas5 proteins do form a stable 
heterodimer that probably constitutes the stable core of all Type I complexes [19], but other 
subunits interact only weakly. The structure of S. solfataricus Cas7 was the first for a Cas7 
subunit from any CRISPR system, revealing a modified RAMP family fold with a central groove 
or cleft that was shown to play a role in crRNA binding [19].  The backbone of all Type I (and 
probably some Type III) complexes is likely to consist of a series of Cas7- like subunits that form 
a helical structure that serves to bind crRNA [19]. 
 
The small subunit, Csa5, is specific to the type I-A systems, but recent structural studies have 
revealed that its fold is related to the C-terminal half of the small subunit of type I-E systems 
(Cse2) [27]. The N-terminal half of Cse2 resembles the fold of the Cmr5 protein, which is the 
small subunit of the type III-B system. Thus the small subunits of type I and III effector complexes 
may all be distantly related, as suggested from a bioinformatics analysis [16]. 
 
Type IIIB (CMR) complex 
Protein components and conformation 
S. Solfataricus P2 genome encodes a type III-B CRISPR-Cas system, known as the CMR 
complex. The complex is comprised of seven subunits, Cmr1-7, and a crRNA component, with 
an overall molecular weight of 430 kDa. Subunits Cmr1-6 may be present as a single copy in the 
complex, whereas the Cmr7 subunit is present at a higher stoichiometry. EM structures are 
available for the full complex and the Cmr2/3/7 subcomplex. The full complex displays cavities 
compatible with an RNA threading machine. The Cmr2/3/7 subcomplex contains no crRNA, 
suggesting a role in RNA binding for Cmr1/4/5/6. Indeed, Cmr1 and Cmr4 are able to bind to 
RNA in vitro (authors’ unpublished data), consistent with the prediction that both proteins have 
RNA-binding RAMP domains [16]. Determination of the path of RNA in the CMR complex in 
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detail remains a key research direction that should help elucidate the catalytic mechanism and 
subunit organisation of the complex. 
 
Features and profile of crRNA in the complex 
Deep sequencing of RNAs bound in the CMR complex revealed that most were crRNAs, with 
variable lengths that centred on 46 nt. Consistent with the variable lengths, some crRNA have a 
short 3’ handle derived from the repeat sequence, while others have very little. By contrast, 
crRNA isolated from the type IA complex have the full 3’ handle. This suggests that further 
maturation of crRNA occurs in the CMR complex, as observed for crRNAs in P. furiosus and S. 
epidermidis type III complexes [28,29]. One possible explanation for the contrast is that the 
Sulfolobus CMR complex might recognise and bind to the 5’ tag sequence of crRNA, leaving its 
free 3’ end susceptible to trimming by an unknown 3’ to 5’ exonuclease. 
 
 
Figure 2. Schematic illustration of crRNA biogenesis and effector complex action in S. 
solfataricus P2.  
 
 
An RNA-dependent ribonuclease 
Although the homology-dependent nuclease activity of the SsoCMR complex has not been 
demonstrated in vivo, the activity has been demonstrated in vitro with the purified whole SsoCMR 
complex. The SsoCMR complex cleaves target RNA in a sequence-specific manner that is 
dependent on the presence of a guide crRNA. A perfect match between the crRNAs and their 
target RNAs, however, is not required for the cleavage reaction, suggesting that the SsoCMR-
based immune system might be effective against a variety of virus variants. The cleavage activity 
of the SsoCMR complex requires manganese and can be stimulated by ATP. The SsoCMR 
complex cleaves single-stranded target RNAs between UA dinucleotides. The cleavage reaction 
requires an intact 5’ tag sequence in crRNAs. Although cleavage of the crRNA as well as the 
target RNA molecule could be observed in vitro, one crRNA molecule in the SsoCMR complex 
can support degradation of multiple molecules of target RNAs [20]. 
 
	   5	  
The large subunit Cas10 (also known as Cmr2) contains a putative cyclase-like domain. The 
domain might bind to Mg2+ and ATP, since the cyclase-like domain in PfuCmr2 is reported to bind 
to ADP and divalent metals [30]. This binding site may be relevant for the ATP stimulation. 
Recently, two crystal structures of the complex between Cmr2 and Cmr3 from PfuCMR have 
revealed a deep channel formed between the subunits. At the foot of this channel lies the most 
conserved “GGDEF” motif of the cyclase domain. One structure reveals two nucleotides bound in 
the channel, suggesting an RNA binding functionality [30]. Together, these data suggest that the 
cyclase domain may recognise the 5’ end of the 8 nt 5’-handle of crRNA with the rest of the 5’ 
handle, which does not participate in target RNA binding, bound in the cleft between the Cmr2 
and Cmr3 proteins. These predictions require further supporting experimental evidence. 
 
Although both SsoCMR and PfuCMR can carry out crRNA-dependent degradation of target 
RNAs, there are at least two major differences between the two complexes. First, in PfuCMR, 
target RNA cleavage site selection uses a ruler mechanism, without discernable sequence 
dependence [31]. The ruler mechanism may be mediated by the active site in one of the RAMP 
subunits that is present at multiple copies and forms the backbone of the complex. In contrast, 
cleavage of RNA by SsoCMR occurs at UA dinucleotides and no ruler mechanism [20]. Second, 
the cleavage products generated by PfuCMR have 3’ phosphate (or 2’, 3 cyclic phosphate) and 
5’ hydroxyl ends, whereas SsoCMR produce 5’ phosphate and 3’ hydroxyl. These differences 
may reflect the plasticity and diversity of the CRISPR-Cas systems and suggest that key 
differences in the nature of the active site in the two systems are likely. Presently, no positive 
identification of the active site has been reported for either Pyrococcus or Sulfolobus CMR. 
 
Concluding remarks and future directions 
Although rapid progress has been made in our understanding of the CRISPR-Cas system in S. 
solfataricus several key questions remain unanswered: 
• Have Cas6 paralogues co-evolved with CRISPR repeat sequences? 
• How are crRNA’s loaded into the diverse effector complexes in S. solfataricus? 
• What is the role of the RNA-targeting type III-B system in CRISPR-mediated antiviral 
defence? 
• How do the three different types of effector complex present in this organism cooperate to 
defend against invading genetic elements? 
• Can the acquisition of new spacers be reconstituted in vitro? 
These questions will shape our research on the CRISPR system in S. solfataricus in the years to 
come. 
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